Pacvue Launches Pacvue Prism, Powering the Industry’s First Agentic Commerce Grid
DoubleVerify Expands DV Authentic AdVantage to Meta and TikTok, an AI-Powered Solution to Optimize Media Quality and Performance
3D AI Studio Launches Flow: Node-Based 3D Workflows That Run in the Browser With No GPU or Setup
Shangri-La Group Debuts ‘Dragonbeat’ with Resounding Success, Cross-Industry Collaborations with Local Creators in Art, Fashion, Gastronomy and Music
EE Power Asia 2026 to Spotlight Technologies Driving the Next Era of Electrification
Company to present BDTX-1535 dose escalation data in NSCLC at the AACR-NCI-EORTC Conference in October…
Proof-of-concept manufacturing to be provided by Cellares for a key Lyell CAR T-cell therapy using…
Proof-of-concept manufacturing to be provided by Cellares for a key Lyell CAR T-cell therapy using…
SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2023 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc….
SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2023 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc….
-Researchers concluded that in the clinical study the HAV was a safe, resilient, and effective…
-Researchers concluded that in the clinical study the HAV was a safe, resilient, and effective…
Biotech industry veteran strengthens leadership team with decades of experience LEXINGTON, Mass., Sept. 11, 2023…
Biotech industry veteran strengthens leadership team with decades of experience LEXINGTON, Mass., Sept. 11, 2023…
Demonstrating potential safety and efficacy of WEE1 inhibitor, ATRN-1051, in the treatment of ovarian cancer…
Demonstrating potential safety and efficacy of WEE1 inhibitor, ATRN-1051, in the treatment of ovarian cancer…
Seattle, Sept. 11, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused…
Seattle, Sept. 11, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused…
The Company intends to increase its existing focus on inflammatory and autoimmune indications. The Company,…
The Company intends to increase its existing focus on inflammatory and autoimmune indications. The Company,…
BASEL, Switzerland and LONDON and NEW YORK, Sept. 11, 2023 (GLOBE NEWSWIRE) — Roivant (Nasdaq:…
BASEL, Switzerland and LONDON and NEW YORK, Sept. 11, 2023 (GLOBE NEWSWIRE) — Roivant (Nasdaq:…
SOUTH SAN FRANCISCO, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
SOUTH SAN FRANCISCO, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
MIAMI, Sept. 11, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN NASDAQ: LGVNR) (“Longeveron” or…